'Haematological cancers, they're a funny bunch': A qualitative study of Non-Hodgkin lymphoma patient experiences of unmet supportive care needs.
Introduction
Being diagnosed with a life threatening illness such as cancer can induce significant levels of emotonal and psychological distress for both patents and their loved ones (Holland and Alici, 2010; Pitceathly and Maguire, 2003) . Haematological cancers are a unique and highly diverse groups of diseases that are known to impact upon a person's wellbeing (Molassiots et al, 2011; Manita et al, 2011; Montgomery et al., 2003) , with key diferences between these diseases and solid cancerous tumours. Yet, there is a lack of published research relatng to the specific unmet supportve care needs that are most pertnent for this patent group (Swash, Hulbert-Williams and Bramwell, 2014) .
Haematological cancers display several key diferences to solid tumours such as breast, lung or colorectal cancer. There are pathological diferences that can afect treatment type, but, perhaps more importantly for patents, which translate into diferences in the organisaton of services; there is a clear degree of separaton from those services aimed at solid tumours (NICE, 2003) . There are also access diferences: people with haematological cancers are more likely to be treated in local district general hospitals rather than specialist cancer units, they are less likely to receive specialist palliatve care, and they are more likely to die in hospital (Howell et al, 2011) . The reasons behind this are complex and not well defined. Treatment for haematological cancers can either be notably intensive, impactng upon social, vocatonal and functonal roles (Sherman et al, 2005) or, conversely, patents may not be treated at all and instead monitored via a 'watch and wait' regime, creatng a mismatch with the common understanding of what will happen when you receive a cancer diagnosis (Evans, Ziebland and Pett, 2012) . In either case, receiving a diagnosis of this kind can have a significant impact upon a person's psychological wellbeing and the way in which they contnue their everyday lives.
As haematological cancers difer from solid tumours in such basic ways, it is difcult to predict the extent to which the most common and disabling psychosocial concerns to afect this patent group may align with those identfied by patents with other cancer diagnoses. Psychosocial needs are theoretcally well defined and this framework has been repeatedly applied within cancer populatons (Sanson-Fisher et al, 2000; Morrison et al, 2012; Armes et al, 2009) . Commonly identfied unmet needs in general cancer groups include: informaton needs, needs relatng to healthcare professionals, and practcal needs (Harrison et al, 2009) . What is less well understood is whether the needs of haematology patents coincide with those of other cancer patents, and to what degree the diferences in presentaton and care result in diferent unmet psychosocial needs, and indeed whether the impact of these needs can provide an explanaton for diferent profiles of psychological wellbeing.
There is a paucity of research that explores the experiences of people diagnosed with lymphoma (Elphee, 2008; Caldwell, 2014) . A thorough understanding of patent experiences and unmet needs is vital if we are to adequately and efectvely implement psychological or supportve care interventons for diferent patent groups. The lack of knowledge of specific needs in haematological cancer are thus a considerable barrier to high quality care. This study aims to investgate: (i) the experiences of psychosocial needs in haematological cancer patents, (ii) why specific needs were felt to be important, and (iii) the impact that unmet needs had on the overall patent experience.
Methodology Procedure
Three small focus groups were conducted with patents with Non-Hodgkin's lymphoma, the most common type of haematological cancer diagnosed in the UK (Cancer Research UK, 2014) . The focus groups were designed to explore the type of needs that patent's had throughout their experiences of diagnosis, treatment and survivorship.
All three focus groups were conducted within a hospital setng in the North West of England, although away from the ward environment for privacy and comfort. Focus groups were audio recorded and subsequently transcribed verbatm. The transcripts were analysed using Interpretatve Phenomenological Analysis (IPA: Smith, 2004; Smith and Osbourn, 2004; Palmer et al, 2010) . The lead researcher completed inital analysis of all transcripts, with all transcripts independently verified by a second researcher. Once a first draf of the results narratve was complete, the second researcher again reviewed the transcripts to provide a second level of validaton to ensure that the analysis framework proposed fited with the raw data accurately. In this way, the validaton of themes became part of the analysis process as it added a further layer to the exploraton and interpretaton of the data.
All focus groups were conducted by the lead researcher, with the assistance of a co-facilitator to help with practcalites. The average length of tme for the focus groups was 90 minutes.
Ethical approval for the study was obtained from NREC and the University of Chester Department of Psychology Ethics Commitee, and local research governance was obtained at the partcipatng NHS trust.
Sample
Partcipants with a diagnosis of a haematological cancer were recruited via Consultant Haematologists in outpatent clinics in a hospital in the North West of England. Informaton packs were provided to partcipants by their Consultant Haematologist during routne clinic appointments, with an opton to speak with the researcher if desired. Partcipants were required to be at least 18 months post-diagnosis and to have completed their treatment regimes. Any haematological cancer diagnosis was initally deemed acceptable for the study; however, all consentng partcipants had a diagnosis of Non-Hodgkin's Lymphoma; this is not surprising given the higher diagnostc rate of this partcular cancer type in the adult populaton. All partcipants were over the age of 18, and were either married or had a long-term partner. 83% of the sample were male. All partcipants had been actvely treated with chemotherapy for their lymphoma, with one partcipant having first been monitored on 'watch and wait'.
Six partcipants were recruited in total. Three focus groups were conducted, each containing two partcipants. Though small, these group sizes were beneficial in order fully explore each partcipant's experience, allowing for each individual narratve to emerge within a shared context, while stll allowing for a direct comparison between experiences within the group.
Interview Schedule
The groups were designed to prompt discussion both with the interviewer, and between partcipants, about the type of needs experienced throughout each patent's cancer experience, and to gain a level of understanding of why some needs were highlighted as important while others deemed not relevant.
The focus groups were facilitated to discuss the following key topics in the following schedule:
1. The majority of the session was spent discussing their met and unmet needs without promptng.
2. To spend some tme looking at the item pool drawn up from existng needs assessment tools (physical, psychological, identty, social, practcal, healthcare professionals, sexual, informaton, communicaton, cognitve functon, financial, spiritual, employment) and to discuss the relevance of items. 3. The comparatve importance of both the needs that they themselves identfied and the needs identfied from the current assessment tools. 4. Partcipants were then asked to highlight their key needs.
Analysis of the data was open and not structured around existng needs, rather the research aimed to determine the extent to which themes generated did correspond with existng needs; and a level of refexivity was used both throughout the focus groups themselves and during the analysis process whereby the researcher was aware of the potental for bias and contnued to queston whether an existng knowledge of unmet needs in cancer was infuencing the current situaton.
Results
Analysis of the data resulted in six super-ordinate themes as presented in Table 1 . Partcipants were assigned pseudonyms, which will be referred to throughout the results secton in order to preserve anonymity. Practcally, what had previously been viewed as simply part of everyday life, now became maters of concern that required atenton.
"I was thinking only the other day that I need to update my will" David However, while present, practcal needs were felt to have been well supported by the healthcare teams at the hospital.
"They do go to quite a lot of efort don't they to find out who you live with, who's there. What your property's like" Mark As a result of needs being met, there was litle in the way of associated psychological distress or anxiety.
This was also refected in how partcipants perceived the presence of physical need. There was an expectaton that cancer would afect physical wellbeing, as such, these needs were expected by partcipants and healthcare professionals who were felt to be geared up to help with this.
"Anything around, if you needed, you know… the washing, the dressing, the sleeping stuf, yeah that was dealt with" Mark It was accepted that cancer treatment would have a physical impact. The physical impact of treatment was perceived to vary across the sample but generally this was a tme when partcipants felt supported due to frequent contact with HCPs. Once treatment ended, however, the level of support available to partcipants was felt to drop away without allowing partcipants tme to acclimatse which was felt by partcipants to be difcult to manage. When combined with the on-going physical efects of cancer treatment, it was at this stage that the physical impact was harder to cope with as this defied the hope that life would return to normal afer treatment.
"It made me so ill. It's taken me… this is my hair now, and I lost it two years last August. And this is all I've stll got so you can imagine (…) but the fact that I've never been as thin as this in my life, and so you feel a mess, a mess in clothes. And so I found it hard to, to… get going to put one foot in front of the other, I was just so exhausted. And, I have to say, stll am a lot of the tme." Daphne
Psychological Needs
Adjustng psychologically to the knowledge that they had cancer was felt to be far more difcult than the physical impact of disease. The inital delivery of the diagnosis was felt to be important and had a real impact on how partcipants perceived their situaton, where conversatons around diagnosis were felt to be less sensitve than would be desired.
"Basically I sat in front of him and he said, "you've got cancer"… what you got is probably incurable, and you need to see a specialist. And then, of you go. So." David Diagnosis was felt to be a crucial tme psychologically: one that had the potental to cause a great deal of anxiety and distress. Once this had been overcome, the end of treatment was also identfied as another pivotal tme in how people coped and adjusted to having cancer. This later tme point is especially pertnent due to the swif and ofen unexpected removal of the safety net of regularly seeing clinicians, frequently being in the cancer treatment setng, and knowing that any concerns could easily be addressed. Being lef to cope alone was difcult. Partcipants described giving their all to 'fightng' their illness, and then being lef empty once the immediate danger had passed.
"I just, having got the all clear and having got that leter, I just… just descended. I just couldn't face anything. And I don't know… I'd just given everything." Ray It was at this point that partcipants' sense of purpose could become lost, and uncertainty around what the future might hold sets in.
The perceptons of others were also felt to be important. There was a need to believe that they would get beter and to keep positve, both from themselves and from those around them. Where this was not the case, the lack of positvity was difcult.
"a lot of people think as soon as you've mentoned cancer, they think god, we'll be burying him soon."
James
The importance of the perceptons of others was a theme that contnued throughout the focus groups.
Partcipants felt that the way in which they were seen by others changed as a result of their cancer diagnosis and ofen meant that people felt labelled as a cancer patent rather than seen as an individual.
"I think, sometmes, when people are ill, some people see the illness and not the individual (…)I think sometmes, if you've had cancer, people see you as a cancer suferer, or a recovering cancer suferer, rather than as John or Fred." David Being treated as an ill person was difcult enough for these partcipants, but being seen as a 'cancer patent' was something even worse as this signified a greater deviaton from one's own sense of self and individuality.
"I didn't want to be defined… I was prety touchy about it (…)it's a small part of my life but it's, you know, I'm very happy that I'm being checked out every year but… did I want people to know at the tme?" Mark This feeling of changes to one's very self was mirrored in changes to the body and body image. Physical changes were felt to be a manifestaton of the disease that signalled to the world that they were ill.
"it was just a way of saying really, look there's, there's this problem." Mark Other more specific areas of psychological need raised were fear of recurrence, maintaining hope, coping and struggling with emotons such as guilt and anger.
The Need to Feel Supported Throughout the Cancer Experience
Feeling supported was important to all partcipants, and where it was absent, the consequent unmet need was felt keenly. Both informal social support and support from healthcare professionals was important. For all partcipants, support from haematology staf, including both the haematologist and haematology nurses, was felt to be of greater relevance than support from primary care clinicians.
Relatonships with family and friends were valued highly, therefore, when support was not forthcoming, the resultng impact was strong.
"I was a litle bit surprised about who kind of put what into the pot." Mark However, partcipants identfied too that maintaining relatonships was difcult when there was so much else going on both practcally and emotonally.
"I didn't want to make contact cos I just couldn't cope cos I was up to here." Daphne Communicaton between the patent and professional was a key determinant of how well supported partcipants felt throughout their cancer experience. Successful communicaton was defined by these partcipants as the giving of clear and individually-tailored informaton, and the way in which informaton was delivered was crucial.
"even though they kept explaining things… they use big words and names of stuf." James Regular contact from clinical staf during the diagnosis and treatment phases was welcomed and created a feeling of being supported. When treatment was completed, however, this sense of support was suddenly absent creatng feelings of isolaton and uncertainty.
"And then you're fired of the end. You're at home aren't you? Well, you are, and I think that maybe that's the tme when…" Mark Given the noted importance of psychological needs, the need to feel that there was support available to address these needs was key. There were diferences between partcipants in the extent to which formal support would have been desired, "I'd rather have somebody prescribe something than deep, psycho, self analysis. It's just not something that I felt, I had a really strong support via my own wife and colleagues and friends" Mark
For those who were more open to receiving support, there was uncertainty around what help was available or how acceptable it was to ask for such help.
"you don't get any interacton with a psychologist or someone who understands these things, if you are feeling depressed, you would probably tend to keep it to yourself because you're sat in a room with 12 other people." David A complicatng factor to feeling supported was the percepton that haematological cancers are diferent from other cancers. There was a feeling that lymphoma is less well recognised and understood that other cancer diagnoses.
"they think cancer's cancer, and it isn't is it?" Mark Haematological cancers were perceived not to fit well with other cancer diagnoses, instead feeling more like living with a chronic illness.
"I'm in remission, and, you know, hope to be so for as long as possible but, there's no outward signs. Now, if you've had aggressive breast cancer and, for instance, you've had a mastectomy… and your body image changes. Whereas here there isn't much to take away, it's all, it's more medicine than surgery and it's more like diabetes that's controlled." David This created a sense of isolaton and separaton both from family and friends who were perceived not to understand what these partcipants were experiencing, but also from other cancer patents who were perceived to have access to beter support services.
"Now if you've got cancer, the Macmillan nurses are superb." Daphne This sense of separaton was compounded by a lack of outward signs of the disease. This was felt to be both positve and negatve, in that it made it easier to get on with everyday life, but at the same tme heightened feelings of diference from both family and peers.
"If you've got, breast cancer, or you have testcular cancer, or prostate cancer or kidney cancer or bowel cancer, or something, you tend to lose, you tend to, you know, I've had colleagues and family members who've had these other forms of specific cancers like that, and they do tend to look ill… Whereas, I
didn't. I haven't lost any weight. I haven't gained any but I haven't lost any. Um, I looked a bit grey the day afer I'd had the chemo… and, what is both a good and a bad thing is that the people who, the people that you meet and who know you've got this, forget it."David While many support services would categorise haematological diagnoses as cancer, partcipants crucially did not and supportve care services were not seen as accessible or relevant to them. Some partcipants did access haematology-specific support groups that were run by natonal charites, but this involved travelling long distances to atend. It was also highlighted how accessing peer support could be problematc, as it is difcult to remain positve about your won prognosis when others with the same diagnosis are seen to be becoming increasingly unwell or pass away.
Barriers to Accessing Support
Psychological needs were repeatedly highlighted as important, yet ofen remained unmet through treatment as partcipants described feeling uncomfortable or unsure about raising their concerns with clinicians.
"I think the support is there if you want it. You just ask. But I think sometmes, do you not think people are afraid to ask? In case, because everyone's busy, I think some people get it in their head, oh I can't, I'd beter not ask in case they're busy." Mark Repeatedly, the busyness of the clinical environment was noted to be a barrier to expressing needs, with clinicians already juggling many tasks, with some (i.e. treatment) taking priority. As such, partcipants did not feel comfortable raising a concern that was seen as an aside to their cancer or their treatment, for fear of wastng the healthcare professional's tme.
"I kept saying that I, I'm sorry, I don't like troubling you." William Hospitals were deemed places where cancer was treated and medical concerns addressed, therefore the physical aspects took predominance over the supportve, and thus psychologically-related concerns were not raised. Partcipants instead put on a 'brave face' and maintained the façade that all was well.
"Unless they've got tme to spend speaking to you, they cannot hear what's happening inside you. And it's the bits you can't see." Ray
Making Sense of the Cancer Experience
Partcipants described feeling a need to make sense of their experiences, and forming comparisons with others was found to be a useful way of doing this while also helping to decrease feelings of isolaton.
Seeing others survive and thrive afer cancer was viewed as a powerful source of hope; seeing others struggle on the hospital ward was difcult, however provided some form of comparison to determine how well they were individually coping.
"looking at others, and the way that some people only get halfway through their first lot of the day and be really struggling… And it's the determinaton of the staf, I felt that they were going about things in such a way that just added to my own determinaton… that I was going to deal with this, they were doing so much and dealing with it so well, that, even if I had a problem, there was no way I could let them know." Ray While forming comparisons could be positve, it could also create feeling of guilt that others were perceived to be coping with worse treatments, symptoms and prognosis. This had the efect of creatng a barrier to asking for help and support from healthcare professionals for these patents who didn't want to take clinicians' atenton away from those with greater need.
Taking control of one's own experience was a powerful force in enabling partcipants to own their experience and to make sense of what was happening to them. "There's nothing you can do about it, you're in the hands of other people who will hopefully do the right thing for you." David
Need for Information
Two aspects of informaton giving were deemed important: first, the actual delivery; and second, ensuring that it was personalised to the individual. These partcipants reported that in their experience the delivery of informaton was generally appropriate. However, the need for clearer, concise informaton was emphasised.
"words of one syllable… and plain, simple English." James
Having informaton about diagnosis and treatment was highly valued, yet the need for the informaton given to be relevant and wanted by the individual was highlighted repeatedly.
"when you first start you get all these generic leafets on, you know, how do you get a wig. I don't need 
Discussion
This paper highlights areas of unmet psychological and supportve care needs that are of partcular relevance to haematology patents. Broadly, the needs discussed by these partcipants can be divided into two groups: those that te in with what we already know about unmet need in cancer, and those that add something new. With the excepton of the themes centred around the specific diferences innate to being a haematology patent and the barriers to accessing support, the themes drawn from these focus groups indicate a level of similarity in the type of unmet need found in patents with difering cancer diagnoses (Armes et al, 2009 ). It may be that for some areas of need, for example physical impact, psychological concerns or practcal maters, that type of need is common across cancer regardless of the specific diagnosis (Harrison et al, 2009 ).
There were recurrent indicatons that, as haematology patents, partcipants felt themselves to be diferent from 'cancer patents': there was the lack of outward signs and the absence of looking 'ill'; the separaton in treatment and associated terminology, for example being treated by haematologists rather than oncologists; and, for some, the modality of treatment was felt to difer, with lymphoma being likened to a chronic health conditon, rather than an acute cancer. These perceived diferences were a cause of frustraton. Feelings of isolaton, of being misunderstood by others, and of being less able to access appropriate support services compared with other cancer patents negatvely impacted these partcipants' cancer experiences. Feelings of isolaton or loneliness as a result of a cancer diagnosis have been highlighted previously (Helgason et al, 2001; Refsgaard and Frederikson, 2013) , yet this has commonly been in relaton to changing lifestyles or altered relatonships with significant others, not as a result of diagnostc categorisaton. Across this sample no partcipant identfied themselves as a 'cancer patent'. Partcipants perceived their diagnosis to be poorly understood by both the general public (from which their informal social support is drawn) and by some healthcare professionals, notably non-cancer professionals such as general practtoners: this was believed to be not the case for other cancers. But, perhaps more importantly, partcipants did not identfy themselves as being cancer patents and this was evident in two distnct ways. First, a widely held belief was that they were primarily haematology (or specifically lymphoma) patents: the perceived diferences between haematological and other cancers afected their views of both how acceptable services such as generic cancer support within the hospital or external charity-led support programmes were, and whether they felt comfortable accessing those support services when they do not identfy as a 'cancer' patent.
Second, some patents simply did not wish to be associated with a 'disease label' at all, and the suggeston that they should adopt the label of 'cancer patent' was felt to be unrefectve of who they believe themselves to be, and the self that they wish to portray to the world. If existng support services are designed with cancer patents in mind, a group to whom partcipants did not feel a sense of belonging, then the applicability of such services to those with a haematological diagnosis may be questoned. These partcipants were clearly unsure about whether these existng cancer services were available, or even relevant, to haematology patents. In the absence of formal support services, partcipants were accessing support through their own social support networks or, in two cases, via disease-specific support groups. It is not clear however, whether these choices were made out of preference for this type of support, or as a results of the perceived lack of alternatves. These findings are novel and have not been reported elsewhere in the psychosocial oncology literature. What we were unable to ascertain from this study, however, was whether this perceptual diference comes from the patents themselves, or whether healthcare and support staf working in both oncology and haematology setngs perceive this diference too.
Patents reported feeling uncomfortable about raising psychosocial issues with their clinicians, a situaton that was compounded by a perceived reluctance from clinicians who also did not typically raise discussion of these kinds of concerns in the oncology clinic; the implicaton of this bi-directonal reluctance is that psychosocial concerns ofen simply weren't discussed with anyone. It has been recognised that clinicians can find it difcult to raise psychological issues with cancer patents, yet NICE cancer patents were ofered a needs assessment and subsequent care plan (Department of Health, 2012) . Training packages have been developed that aim to improve clinician efcacy at detectng and managing distress within a general healthcare setng (Merckaert et al, 2005; Fallowfield et al, 2002) .
While these kinds of training programmes do seem to improve clinician confidence in their abilites and short-term competence (Fallowfield et al, 2003) , there is less convincing evidence as to whether there are also improvements in ability to accurately detect distress or whether ultmately patent experience is improved (Moorey, 2013) . The idea that cancer professionals do not always accurately detect the presence of psychological morbidity is not new (e.g. Fallowfield et al, 2001 ) and further work is needed to extrapolate the current evidence base in order to improve clinician confidence in raising psychological concerns with patents and to ultmately improve the patent experience.
This work also highlights barriers that are preventng patents who would benefit from psychological support from atemptng to access this. If healthcare professionals do not raise psychosocial concerns within the clinic, and patents do not feel able to do so themselves, these needs will inevitably be lef unaddressed. The need for HCPs to raise concerns and to feel confident in their abilites to do so is key.
Existng research highlights the fact that many HCPs feel a lack of confidence in their ability to manage psychological distress (Moorey, 2013) , as such there has been an infux of training programmes that aim to improve confidence and efcacy. Evaluatons of these programmes have found that they do improve confidence but it is unclear as to whether there are also improvements in clinician ability to accurately detect distress and whether patent experiences are ultmately improved.
While this study provides a valuable insight into the lived experiences of psychosocial needs in haematological cancer patent, it also highlights the need for ongoing and systematc quanttatve assessment of unmet need in haematology, just as is recommended for other cancer groups (Watson et al, 2012) . From a research perspectve, there is a need for large cohort studies, ideally with multple types of haematological diagnoses, recruited to inform the sector about the unmet needs of diferent patent groups, and to supplement this work on ideographic patent experiences. Recommendatons by the Natonal Cancer Survivorship Initatve (2010) include the use of cohort studies as a way of mapping areas of need within cancer survivorship and as a method to develop priorites for future studies. There is also a need to beter understand the supportve care preferences of this patent group. It became apparent within this sample that partcipants had not accessed support services that were designed for 'cancer patents', despite their unmet needs not appearing to difer greatly. Future research should seek to establish whether a change in how existng support services are marketed to patents would increase uptake, or whether haematological cancer patents would prefer to access support services that are targeted towards their specific patent group.
There are both benefits and limitatons of conductng a study with a small sample size. The intenton of this study was to beter understand patent experiences of need during cancer and how unmet needs impacted upon overall wellbeing; however, this does mean that applicability to the wider patent populaton is problematc. Indeed, given the qualitatve epistemology of this study, applicaton of the findings to a whole patent populaton was not the objectve of the work. Rather, this study was designed to provide a depth and richness that could fit alongside subsequent quanttatve works from which wider generalisaton could be inferred. The small sample was, in part refectve of challenges encountered when atemptng to recruit partcipants into the study. While homogeneity within the sample was appropriate given the use of IPA, it does refect a wider problem within psychosocial oncology research in atemptng to recruit diverse samples that refect society within the UK today.
However, the dominance of males within the sample was deemed positve as men are typically harder to engage in psychosocial oncology research than women. Indeed, difculty recruitng cancer patents into psychosocial studies is a challenge beyond that presented within this paper and is a challenge for psychosocial research in the UK today.
In conclusion, this work demonstrates a clear perceived diference between haematological cancer patents and other cancer patent groups. Though drawn from a small sample, this work is novel and has direct implicatons for both how these patents identfy themselves, and in reducing the perceived acceptability of support services that are designed for general cancer patent populatons.
Understanding which unmet needs are most prominent is the crucial first step in designing interventons and clinical services to begin to meet those needs, and this work clearly demonstrates the potental psychological impacts of such needs remaining unmet.
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